Differential responsiveness to interferon-α in β-cells and non-β-cells

Diabetes

Volumn 45, Issue 6, 1996, Pages 818-821

  Bonnevie Nielsen, V ^a   Buschard, K ^b   Dyrberg, T ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; GLUCAGON; INSULIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

EID: 0029931411     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.45.6.818     Document Type: Article

References (26)

1. King ML, Bidwell D, Shaikh A, Voller A, Banatvala JE: Coxsakie-B-virus specific IgM responses in children with insulin-dependent diabetes mellitus. Lancet i: 1397-1399, 1983
2. Yoon J-W, Onodera T, Notkins AL: Virus-induced diabetes mellitus: beta cell damage and insulin-dependent hyperglycemia in mice infected with Coxsackie virus B4. J Exp Med 148:1068-1080, 1978
3. Yoon J-W: A new look at viruses in type-1 diabetes. Diabetes Metab Rev 11:83-107, 1995
4. Bonnevie-Nielsen V, Larsen ML, Frifelt JJ, Michelsen B, Lernmark Å: Association of IDDM and attenuated response of 2′,5′-oligoadenylate synthetase to yellow fever vaccine. Diabetes 38:1636-1642, 1989
5. Revel M, Kimchi A, Shulman L, Fradin A, Shuster R, Yakobson E, Chernajovsky Y, Schmidt A, Shure A, Bendori R: Role of interferon-induced enzymes in the antiviral and antimitogenic effects of interferon Ann NY Acad Sci 350:459-472, 1980
6. Foulis AK, McGill M, Farquharson MA: Insulin in type 1 (insulin-dependent) diabetes mellitus in man: macrophages, lymphocytes, and interferon-γ containing cells. J Pathol 165:97-103, 1991
7. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319-331, 1991
8. Bonnevie-Nielsen V, Stoffes MW, Lernmark Å: A major loss in islet mass and B-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 30:424-429, 1981
9. Revel M, Chebath J: Interferon-activated genes. TIBS 2:106-170, 1986
10. Hovanessian A: Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′,5′-oligoadenylate synthetases. J Interferon Res 11:199-205, 1991
11. Pestka S, Langer JA, Zoon KC, Samuel CE: Interferons and their actions. Ann Rev Biochem 56:727-777, 1987
12. Rhodes C, Taylor KW: 2-5A-dependent endoribonuclease activity and effects of A2′ p5′ A2′ p5′ A (2-5A core) in mouse pancreatic islets. FEBS Lett 180:69-73, 1985
13. Bonnevie-Nielsen V, Gerdes A-M, Fleckner J, Petereen JS, Michelsen B, Dyrberg T: Interferon stimulates the expression of 2′,5′-oligoadenylate synthetase and MHC Class I antigens in insulin-producing cells. J Interferon Res 11:255-260, 1991
14. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Bækkeskov S: Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci 85:9037-9042, 1988
15. Efrat S, Teigleman G, Anwar M, Ruggiori D, Hanahan D: Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic alpha cells. Neuron 1:605-013, 1988
16. Justesen J, Ferbus D, Thang MN: 2′5′Oligo-adenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2′5′ oligoadenylates and 2′5′ co-oligonucleotides. Nucleic Acids Res 8:3073-3085, 1980
17. Buschard K, Aaen K, Horn T, van Damme J, Bendtzen K: Interleukin 6 is a functional and structural modulator of beta cells from islets of Langerhans. Autoimmunity 5:185-194, 1990
18. Buschard K, Josefsen K, Hansen SV, Horn T, Marshall MO, Persson H, Månsson J-E, Fredman P: Sulphatide in islets of Langerhans and in organs affected in diabetic late complications: a study in human and animal tissue. Diabetologia 37:1000-1000, 1994
19. Huang X, Hultgren B, Dybdal N, Stewart TA: Islet expression of interferon-α precedes diabetes in both the BB rat and streptozotocin treated mice. Immunity 1:469-478, 1994
20. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA: Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52:773-782, 1988
21. Stewart T, Hultgren R, Huang X, Pitts-Meek S, Hulty J, Maclachlan NJ: Induction of type 1 diabetes by interferon-α in transgenic mice. Science 260:1942-1940, 1993
22. Huang X, Yuan J, Goddard A, Foulis A, James RFL, Lernmark A, Pujol-Borell R, Rabinovitch A, Somoza N, Stewart TA: Interferon expression in the pancreases of patients with type 1 diabetes. Diabetes 44:658-664, 1995
23. Waguri M, Hanafusa T, Itoh N, Imagawa A, Miyagawa J, Kawata S, Kono N, Kuwajima M, Matsuzawa Y: Occurrence of IDDM during Interferon therapy for chronic viral hepatitis. Diabetes Res Clin Pract 23:33-36, 1994
24. Guerci A-P, Guerci B, Lèvy-Marchal C, Ongagna J, Ziegler O, Candiloros H, Guerci O, Drouin P: Onset of insulin-dependent diabetes mellitus after interferon-alfa therapy for hairy cell leukaemia. Lancet i:1167-1168, 1994
25. Witt PL, Marié I, Robert N, Irizarry A, Borden EC: Isoforms p69 and p100 of 2′,5′-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro. J Interferon Res 13:17-23, 1993
26. Marié I, Svab J, Hovanessian A: The binding of the 69- and 100-kD forms of 2′,5′-oligoadenylate synthetase to different polynucleotides. J Interferon Res 10:571-578, 1990